-
-
-
-
-
-
-
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.
-
-
-
-
-
-
-
Barclays Downgrades Terns Pharmaceuticals (TERN) to Equalweight
-
-
-
-
-
-
-
Merck to buy oncology firm Terns Pharmaceuticals in $6.7 billion deal
-
-
-
-
-
-
-
Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors
-
-
-
1,160,146 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

